For pharmaceutical and medical device companies, translation is not simply the final language step before global commercialization. It is an essential part of regulatory submissions, market access, and safe product use.
A regulatory dossier, a medical device Instructions for Use (IFU), or a clinical trial document must accurately communicate specialized information across different languages while meeting the regulatory requirements and industry standards of target markets.
In general business documents, a language inconsistency may only affect readability. However, in the life sciences sector, a misunderstanding of a technical term or an inconsistency in critical information can increase review and communication efforts, delay project progress, or create additional compliance risks.
This is why life sciences translation has long been regarded as one of the most demanding areas within professional language services.
So, what makes life sciences translation so challenging? And what capabilities should companies look for when selecting a language service provider?
1. What Is Life Sciences Translation? Why Does It Require Higher Standards Than General Translation?
Life sciences translation covers specialized content in areas such as pharmaceuticals, medical devices, biotechnology, and clinical research, including:
- Pharmaceutical regulatory submission documents;
- Drug labels and prescribing information;
- Medical device technical documentation and Instructions for Use (IFU);
- Clinical trial protocols and Informed Consent Forms (ICF);
- Medical research reports and related regulatory documents.
These documents are often used in critical stages including product development, regulatory review, market approval, and clinical application. As a result, they require a much higher level of accuracy and reliability.
Compared with general business translation, the key difference in life sciences translation is that translated content must satisfy both technical accuracy and real-world application requirements.
On one hand, these documents contain extensive medical, pharmaceutical, and engineering information, requiring translators to fully understand complex concepts and accurately convey their meaning.
On the other hand, different document types serve different purposes and must be handled according to their specific functions and usage scenarios.
For example:
Pharmaceutical regulatory documents support regulatory review and require consistent terminology and standardized expressions;
Medical device IFUs are intended for end users and must communicate safety information and operating instructions clearly and accurately;
Clinical trial documents must ensure that researchers, regulatory authorities, and study participants can correctly understand essential information throughout the study process.
Therefore, life sciences translation is not simply a process of converting words from one language into another. It requires a combination of scientific knowledge, document purpose, and industry standards to ensure accurate information transfer.
2. Why Does Life Sciences Translation Require “Near-Zero Error Tolerance”?
The strict accuracy requirements in life sciences come from the critical role these documents play.
In general content, differences in wording may not cause significant consequences. However, documents related to pharmaceuticals, medical devices, and clinical research often contain terms with clearly defined medical meanings and specific requirements for use.
For example:
In pharmaceutical documents, information such as indications, contraindications, and adverse reactions must follow standardized regulatory expressions;
In medical device documentation, risk warnings and operating instructions must be understood accurately by users;
In clinical research materials, key information must be communicated consistently throughout the study process.
Therefore, life sciences translation is ultimately about ensuring that documents remain accurate and usable within real business and regulatory workflows.
In practice, the challenges companies encounter are often not obvious translation errors, but subtle inconsistencies. For example, the same product name may be translated differently across documents, or a technical concept may be interpreted differently at different stages of development.
These issues can increase communication efforts during regulatory review and create additional maintenance costs over the product lifecycle.
To address these challenges, professional life sciences translation projects typically rely on terminology management, structured review processes, and quality control mechanisms to maintain consistency and reduce uncertainty throughout the project.
3. What Are the Key Challenges in Pharmaceutical Regulatory Translation?
One common misconception about pharmaceutical regulatory translation is that the main challenge is simply the large number of specialized terms involved.
In reality, the complexity of pharmaceutical regulatory translation lies in the fact that every term is connected to medical knowledge, drug development processes, and regulatory requirements.
3.1 Terminology Must Follow Industry and Regulatory Standards
Pharmaceutical regulatory documents contain a large number of standardized expressions related to drug names, mechanisms of action, clinical data, safety information, and more.
These terms cannot be translated based only on their literal meanings. They require an understanding of the specific regulatory context in which they are used.
If the same concept is expressed differently across regulatory submissions, clinical study reports, and post-marketing documents, it may affect overall document consistency and increase the complexity of regulatory communication.
3.2 Translators Must Understand the Medical Logic Behind Terminology
Life sciences translation cannot be completed simply by finding equivalent words in a dictionary.
Translators need to understand relevant medical concepts and determine the most accurate interpretation based on the specific context.
For example, certain medical events reported in clinical studies require interpretation based on surrounding information, such as the study protocol and safety reports, rather than being translated as isolated terms.
3.3 Long-Term Language Asset Management Is Essential
Drug development and regulatory approval are usually long-term processes. A single product may go through multiple development stages, regulatory submissions, and document updates.
If every translation project starts from scratch, efficiency decreases and terminology inconsistencies become more likely.
For this reason, professional life sciences translation projects often rely on terminology databases, translation memories, and structured review workflows to manage key expressions consistently.
Based on industry experience, the most overlooked challenge in pharmaceutical regulatory translation is often not handling complex sentences, but maintaining consistency throughout long-term projects.
A translation team suitable for this field needs more than language proficiency. It requires a combination of linguistic expertise, scientific knowledge, and project management capabilities.
4. Why Is Medical Device IFU Translation More Than Just Language Conversion?
If the core challenge of pharmaceutical regulatory translation lies in the accuracy of medical terminology and regulatory expressions, the complexity of medical device Instructions for Use (IFU) translation lies more in balancing product information, safety requirements, and real-world usage scenarios.
An IFU is not simply a document that introduces product features. It serves as an important reference that guides users on how to operate a device correctly, understand potential risks, and avoid improper use.
Therefore, IFU translation requires more than accurately conveying the source content. It must ensure that users can clearly understand the device functions, operating procedures, and safety instructions in the translated version.
4.1 Product Information Must Meet Target Market Requirements
Medical device documentation often covers multiple aspects, including product structure, operating procedures, risk warnings, maintenance requirements, and other technical information.
These elements may follow different documentation practices and regulatory expectations across markets. For example, certain safety warnings, risk classifications, and operating instructions need to align with the terminology and communication standards commonly used in the target market.
A word-for-word translation may appear linguistically correct, but it may not necessarily satisfy regulatory review requirements or meet users’ actual needs.
4.2 Multilingual Versions Must Maintain Overall Consistency
For medical device companies expanding into multiple countries and regions, the same product often requires IFUs in multiple languages.
The challenge is not simply the increasing volume of translation work, but maintaining consistent information across different language versions.
Without effective terminology management and version control, inconsistencies may occur between language versions, making future updates and maintenance more difficult.
Therefore, medical device IFU translation evaluates not only the quality of individual documents, but also the service provider’s ability to manage complex multilingual projects.
5. Why Does Clinical Trial Translation Require Strong Consistency Management?
The unique challenge of clinical trial translation is that it is not a one-time language conversion. Instead, it is an ongoing language management process throughout the entire research lifecycle.
A clinical trial usually involves multiple stages and a large number of related documents, including:
- Clinical Trial Protocol;
- Informed Consent Form (ICF);
- Investigator’s Brochure (IB);
- Case Report Form (CRF);
- Safety reports and other medical documents.
These documents are highly interconnected.
For example, descriptions of adverse events, definitions of study endpoints, and names of treatment regimens must remain consistent across different documents and versions.
If translation is not managed systematically at the early stages, terminology may change during later updates, potentially causing misunderstandings among researchers, regulatory authorities, or study participants.
Therefore, the real challenge in clinical trial translation is not only the accuracy of individual sentences, but also maintaining information consistency across multiple documents, different study phases, and various language versions.
Professional life sciences translation projects typically establish project-specific terminology databases and translation memories to standardize key terms, product names, study-related expressions, and other critical content before translation begins.
For companies conducting international clinical research over the long term, these language assets can improve translation efficiency while reducing future project management costs.
6. How Can Companies Evaluate Whether a Life Sciences Translation Provider Is Professional?
For pharmaceutical and medical device companies, selecting a life sciences translation provider should go beyond comparing language coverage or individual project pricing.
More importantly, companies need to evaluate whether the provider has the expertise and operational capabilities required to manage complex professional projects.
6.1 Does the Provider Have Relevant Life Sciences Experience and Specialized Resources?
Life sciences translation involves multiple disciplines, including medicine, pharmaceuticals, engineering, and regulatory requirements.
A professional translation team typically requires translators and reviewers with relevant subject matter knowledge who can understand the underlying scientific logic rather than simply convert text between languages.
When evaluating a provider, companies may consider whether the provider has experience in areas such as pharmaceutical regulatory submissions, medical device documentation, and clinical research projects, as well as whether it maintains relevant quality certifications, such as ISO 13485.
6.2 Does the Provider Have Effective Terminology Management and Quality Control Systems?
Life sciences projects often involve large volumes of documents, multiple language versions, and continuous updates over time.
Without a systematic quality management approach, maintaining consistent quality through individual experience alone can be difficult.
Professional language service providers typically use terminology databases, translation memories, independent review processes, and structured project workflows to control critical content.
For example, Glodom leverages its long-term experience in language services to accumulate specialized terminology resources and project management expertise in the life sciences sector. By combining professional workflows with language technology solutions, Glodom helps improve consistency and delivery efficiency in multilingual projects.
6.3 Does the Provider Understand Regulatory Requirements in Different Markets?
When life sciences products enter different countries and regions, companies need to comply with different regulatory systems.
A capable translation provider must understand not only language differences, but also the documentation expectations and regulatory requirements of different markets.
For example:
The U.S. market commonly involves requirements related to the U.S. Food and Drug Administration (FDA);
The European market involves regulatory frameworks associated with the European Medicines Agency (EMA) and medical device regulations;
The Chinese market involves registration requirements from the National Medical Products Administration (NMPA).
Even when a translation is linguistically accurate, a lack of understanding of target-market requirements may still result in additional revisions and increased project costs.
7. Why Is Life Sciences Translation More Expensive Than General Translation?
Compared with general content translation, life sciences translation usually requires greater investment in specialized resources, resulting in relatively higher costs.
This difference mainly comes from several factors:
- Higher expertise requirements: projects often require translators with backgrounds in medicine, pharmaceuticals, or related fields;
- More complex quality control processes: professional workflows typically include terminology management, translation, and review stages;
- More demanding project management: teams need to handle multiple documents, different versions, and long-term maintenance requirements.
The value of these processes lies in reducing future rework and communication costs.
For companies pursuing global registration and commercialization, translation fees represent only one part of the overall internationalization investment.
However, delays in regulatory approval, document revisions, and project adjustments caused by translation issues can create significantly higher time costs.
Therefore, the goal of life sciences translation is not simply to pursue the lowest price, but to achieve an appropriate balance between risk control and project efficiency.
8. How Can Life Sciences Translation Balance Quality and Cost? Glodom’s Risk-Based Delivery Approach
Through years of serving life sciences clients, we have found that companies often face a practical challenge in translation management:
Applying the highest quality standards to every document can create significant cost pressure, while simply pursuing lower costs may affect the compliance and reliability of critical content.
Therefore, cost optimization in life sciences translation is not about reducing essential quality controls. Instead, it requires allocating resources appropriately based on document importance, usage scenarios, and risk levels.
Based on this approach, Glodom has developed a tiered delivery model built around document risk assessment, professional resource allocation, language technology application, and quality management workflows. This approach helps clients maintain reliable quality while improving translation efficiency and overall project value.
8.1 For High-Risk Documents, Glodom Prioritizes Specialized Resources to Support Regulatory and Compliance Requirements
For core documents that directly affect product registration, market access, and user safety, such as pharmaceutical regulatory submission documents, medical device Instructions for Use (IFU), clinical trial protocols, and Informed Consent Forms (ICF), Glodom applies a comprehensive quality control process.
Quality assurance focuses on several key areas:
(1) Professional Translator Matching
Glodom assigns translators based on document type and required expertise, selecting professionals with experience in medicine, pharmaceuticals, life sciences, or related industries.
This ensures that translators understand not only the language itself, but also the technical content and practical application scenarios behind the documents.
(2) Centralized Terminology Management
At the beginning of a project, Glodom establishes project-specific terminology databases to manage critical information such as product names, disease names, treatment protocols, and medical device descriptions.
For companies conducting global registrations over the long term, these terminology assets can be continuously reused during document updates and multilingual expansion, reducing repeated terminology confirmation efforts.
(3) Multi-Level Quality Review
Critical documents typically go through multiple quality stages, including translation, subject matter review, and linguistic review.
These processes focus on terminology accuracy, content consistency, and compliance with target-market documentation standards.
By integrating quality control throughout the translation process, companies can reduce rework and communication costs caused by translation issues at later stages.
8.2 For Lower-Risk Documents, Glodom Uses Language Technology and Standardized Workflows to Improve Efficiency
Internal training materials, general communication documents, and other lower-risk content may belong to the life sciences domain, but they usually do not directly affect regulatory review or product safety.
For these types of documents, Glodom improves efficiency through technology-enabled workflows and standardized processes.
(1) Using Language Technology to Manage Repetitive Content
Throughout long-term life sciences projects, Glodom’s G-Tranx translation platform continuously accumulates client-specific language assets, including approved terminology, previous translations, and project-specific rules.
When the same product enters new markets or undergoes document updates, existing language resources can be reused to reduce repetitive translation work and manual confirmation efforts.
(2) Applying Standardized Workflows for Multilingual and High-Volume Projects
For multilingual projects involving multiple batches of documents, establishing templates, terminology guidelines, and delivery standards in advance helps reduce repeated communication and improves overall execution efficiency.
By allocating resources according to risk levels, companies can avoid applying the same level of investment to every document while still ensuring quality where it matters most.
This approach improves overall management efficiency for life sciences translation projects.
9. Conclusion
As pharmaceutical, medical device, and life sciences companies accelerate their global expansion, language requirements throughout regulatory submission, research collaboration, and product commercialization are becoming increasingly complex.
What companies need is not simply one-time document translation, but long-term language management capabilities — including continuous terminology development, multilingual content consistency, and quality control for complex global projects.
This evolution is driving life sciences language services beyond traditional translation delivery toward comprehensive solutions that combine specialized expertise, language technology, and project management capabilities.
As a technology-driven language technology solutions provider, Glodom continues to build industry expertise, language assets, and project management capabilities in highly specialized fields such as life sciences.
By combining professional resources with language technology solutions, Glodom supports companies throughout global registration, product commercialization, and long-term international growth with reliable language services.
